Table 3 Univariate and multivariate analysis for AIP index predicting the occurrence of MACEs within 2 years after PCI

AIP index

 Tertile 1

Ref

Ref

Ref

Ref

Ref

Ref

 Tertile 2

0.96

0.71–1.30

0.801

0.93

0.69–1.27

0.656

 Tertile 3

1.37

1.04–1.81

0.025*

1.36

1.01–1.82

0.042*

Age

1

0.99–1.01

0.95

1.00

0.99–1.01

0.849

BMI

1.02

0.98–1.05

0.41

1.05

0.97–1.05

0.687

Male

0.94

0.70–1.25

0.66

0.89

0.59–1.34

0.567

CCS

1.08

0.85–1.36

0.551

1.05

0.82–1.34

0.722

Hypertension

1.02

0.80–1.29

0.894

0.97

0.74–1.28

0.852

Hyperlipidemia

1.2

0.94–1.53

0.152

1.10

0.86–1.42

0.448

Renal dysfunction

1

0.79–1.27

0.993

0.91

0.63–1.32

0.632

Smoker

1

0.79–1.26

0.986

0.92

0.70–1.21

0.551

Cerebrovascular diseases

1.31

0.91–1.88

0.145

1.24

0.86–1.80

0.255

COPD

0.76

0.31–1.84

0.542

0.75

0.31–1.83

0.522

Previous myocardial infarction

1.24

0.98–1.57

0.075

1.06

0.81–1.38

0.676

Previous CABG

1.76

1.08–2.87

0.024*

1.35

0.81–2.26

0.253

Previous PCI

1.63

1.27–2.10

< 0.001*

1.50

1.15–1.95

0.003*

Peripheral vascular diseases

2.69

1.52–4.45

< 0.001*

2.60

1.50–4.49

0.001*

Creatine, umol/l

1

0.99–1.01

0.869

0.99

0.98–1.01

0.321

Albumin, g/l

0.99

0.96–1.01

0.305

0.99

0.96–1.02

0.47

Left main involved, %

1.03

0.63–1.69

0.897

0.88

0.53–1.45

0.611

CTO

2.37

1.75–3.21

< 0.001*

2.14

1.56–2.93

< 0.001*

TVD

1.75

1.39–2.20

< 0.001*

1.68

1.38–2.04

< 0.001*

β-blocker at discharge

1.11

0.78–1.56

0.569

1.04

0.74–1.48

0.81

Statin at discharge

0.59

0.36–0.98

0.042*

0.57

0.35–0.95

0.031*

ACEI/ARB at discharge

1.06

0.84–1.33

0.649

1.00

0.77–1.29

1

CCB at discharge

0.82

0.65–1.04

0.094

0.84

0.65–1.08

0.163